Development and characterization of monoclonal antibodies to yellow fever virus and application in antigen detection and IgM capture enzyme-linked immunosorbent assay

Clinical and Vaccine Immunology

Volumn 23, Issue 8, 2016, Pages 689-697

  Adungo, Ferdinard ^a,b   Yu, Fuxun ^a   Kamau, David ^a   Inoue, Shingo ^a   Hayasaka, Daisuke ^a   Posadas Herrera, Guillermo ^a,c   Sang, Rosemary ^b   Mwau, Matilu ^b   Moritaa, Kouichi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DENGUE VACCINE; ENVELOPE PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; JAPANESE ENCEPHALITIS VACCINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3B6; MONOCLONAL ANTIBODY 3F4; MONOCLONAL ANTIBODY 4A1; MONOCLONAL ANTIBODY 4C9; MONOCLONAL ANTIBODY 4H10; MONOCLONAL ANTIBODY 5B6; MONOCLONAL ANTIBODY 5H2; MONOCLONAL ANTIBODY 8H3; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS E PROTEIN; IMMUNOLOGIC FACTOR; PROTEIN BINDING; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS REACTION; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUCROSE GRADIENT; VIRUS NEUTRALIZATION; WESTERN BLOTTING; WILD TYPE; YELLOW FEVER; YELLOW FEVER VIRUS; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DIAGNOSTIC TEST; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PROCEDURES;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; DIAGNOSTIC TESTS, ROUTINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTORS; MICE, INBRED BALB C; PROTEIN BINDING; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS; YELLOW FEVER; YELLOW FEVER VIRUS;

EID: 84983003959     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00209-16     Document Type: Article

References (48)

1. Fauquet CM, Fargette D. 2005. International Committee on Taxonomy of Viruses and the 3, 142 unassigned species. Virol J 2:64. http://dx.doi.org/10.1186/1743-422X-2-64.
2. Lindenbach BD, Rice CM. 2001. Flaviviridae: the viruses and their replication, p 991-1041. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
3. WHO. 2014. Yellow fever fact sheet. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs100/en/. Accessed 3 October 2014.
4. Monath TP. 2001. Yellow fever: an update. Lancet Infect Dis 1:11-20. http://dx.doi.org/10.1016/S1473-3099 (01) 00016-0.
5. Garske T, Van Kerkhove MD, Yactayo S, Ronveaux O, Lewis RF, Staples JE, Perea W, Ferguson NM. 2014. Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data. PLoS Med 11:e1001638. http://dx.doi.org/10.1371/journal.pmed.1001638.
6. Onyango CO, Grobbelaar AA, Gibson GV, Sang RC, Sow A, Swaneopel R, Burt FJ. 2004. Yellow fever outbreak, southern Sudan, 2003. Emerg Infect Dis 10:1668-1670. http://dx.doi.org/10.3201/eid1009.030727.
7. Gould LH, Osman MS, Farnon EC, Griffith KS, Godsey MS, Karch S, Mulenda B, El Kholy A, Grandesso F, de Radigues X, Brair ME, Briand S, El Tayeb el SM, Hayes EB, Zeller H, Perea W. 2008. An outbreak of yellow fever with concurrent chikungunya virus transmission in South Kordofan, Sudan, 2005. Trans R Soc Trop Med Hyg 102:1247-1254. http://dx.doi.org/10.1016/j.trstmh.2008.04.014.
8. Sanders EJ, Marfin AA, Tukei PM, Kuria G, Ademba G, Agata NN, Ouma JO, Cropp CB, Karabatsos N, Reiter P, Moore PS, Gubler DJ. 1998. First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations. Am J Trop Med Hyg 59:644-649.
9. McMullan LK, Frace M, Sammons SA, Shoemaker T, Balinandi S, Wamala JF, Lutwama JJ, Downing RG, Stroeher U, MacNeil A, Nichol ST. 2012. Using next generation sequencing to identify yellow fever virus in Uganda. Virology 422:1-5. http://dx.doi.org/10.1016/j.virol.2011.08.024.
10. WHO. 2011. Outbreak news. Yellow fever, Uganda. Wkly Epidemiol Rec 86:37-38.
11. Soghaier MA, Hagar A, Abbas MA, Elmangory MM, Eltahir KM, Sall AA. 2013. Yellow fever outbreak in Darfur, Sudan in October 2012; the initial outbreak investigation report. J Infect Public Health 6:370-376. http://dx.doi.org/10.1016/j.jiph.2013.04.007.
12. Monath TP, Vasconcelos PF. 24 October 2014. Yellow fever. J Clin Virol http://dx.doi.org/10.1016/j.jcv. 2014.08.030.
13. Barrett AD, Higgs S. 2007. Yellow fever: a disease that has yet to be conquered. Annu Rev Entomol 52:209-229. http://dx.doi.org/10.1146/annurev. ento.52.110405.091454.
14. Jentes ES, Poumerol G, Gershman MD, Hill DR, Lemarchand J, Lewis RF, Staples JE, Tomori O, Wilder-Smith A, Monath TP. 2011. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. Lancet Infect Dis 11:622-632. http://dx.doi.org/10.1016/S1473-3099 (11) 70147-5.
15. Mutebi JP, Barrett AD. 2002. The epidemiology of yellow fever in Africa. Microbes Infect 4:1459-1468. http://dx.doi.org/10.1016/S1286-4579 (02) 00028-X.
16. Drosten C, Gottig S, Schilling S, Asper M, Panning M, Schmitz H, Gunther S. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 40:2323-2330. http://dx.doi.org/10.1128/JCM.40.7.2323-2330.2002.
17. Bae HG, Nitsche A, Teichmann A, Biel SS, Niedrig M. 2003. Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J Virol Methods 110:185-191. http://dx.doi.org/10.1016/S0166-0934 (03) 00129-0.
18. Nunes MR, Palacios G, Nunes KN, Casseb SM, Martins LC, Quaresma JA, Savji N, Lipkin WI, Vasconcelos PF. 2011. Evaluation of two molecular methods for the detection of yellow fever virus genome. J Virol Methods 174:29-34. http://dx.doi.org/10.1016/j.jviromet.2011.02.025.
19. Kwallah A, Inoue S, Muigai AW, Kubo T, Sang R, Morita K, Mwau M. 2013. A real-time reverse transcription loop-mediated isothermal amplification assay for the rapid detection of yellow fever virus. J Virol Methods 193:23-27. http://dx.doi.org/10.1016/j.jviromet.2013.05.004.
20. Nunes MR, Vianez JL, Jr, Nunes KN, da Silva SP, Lima CP, Guzman H, Martins LC, Carvalho VL, Tesh RB, Vasconcelos PF. 2015. Analysis of a reverse transcription loop-mediated isothermal amplification (RTLAMP) for yellow fever diagnostic. J Virol Methods 226:40-51. http://dx.doi.org/10.1016/j.jviromet.2015.10.003.
21. Escadafal C, Faye O, Sall AA, Weidmann M, Strohmeier O, von Stetten F, Drexler J, Eberhard M, Niedrig M, Patel P. 2014. Rapid molecular assays for the detection of yellow fever virus in low-resource settings. PLoS Negl Trop Dis 8:e2730. http://dx.doi.org/10.1371/journal.pntd.0002730.
22. Vazquez Y, Pupo-Antúnez M, Vazquez SV, Capó V, Torres G, Caballero Y, Sánchez A, Limonta D, Alvarez M, Guzmán MG. 2009. Monoclonal antibody to dengue capsid protein: its application in dengue studies. MAbs 1:157-162. http://dx.doi.org/10.4161/mabs.1.2.7908.
23. Liu J, Liu B, Cao Z, Inoue S, Morita K, Tian K, Zhu Q, Gao GF. 2008. Characterization and application of monoclonal antibodies specific to West Nile virus envelope protein. J Virol Methods 154:20-26. http://dx.doi.org/10.1016/j.jviromet.2008.09.019.
24. Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, Chin C, Lin TH, Huang JH. 2001. Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination. Vaccine 19:1753-1763. http://dx.doi.org/10.1016/S0264-410X (00) 00391-1.
25. Ding XX, Li XF, Deng YQ, Guo YH, Hao W, Che XY, Qin CF, Fu N. 2014. Development of a double antibody sandwich ELISA for West Nile virus detection using monoclonal antibodies against non-structural protein 1. PLoS One 9:e108623. http://dx.doi.org/10.1371/journal.pone.0108623.
26. Gelanew T, Poole-Smith BK, Hunsperger E. 2015. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1). J Virol Methods 222:214-223. http://dx.doi.org/10.1016/j.jviromet.2015.06.003.
27. Choi KS, Ko YJ, Nah JJ, Kim YJ, Kang SY, Yoon KJ, Joo YS. 2007. Monoclonal antibody-based competitive enzyme-linked immunosorbent assay for detecting and quantifying West Nile virus-neutralizing antibodies in horse sera. Clin Vaccine Immunol 14:134-138. http://dx.doi.org/10.1128/CVI.00322-06.
28. Stock NK, Escadafal C, Achazi K, Cisse M, Niedrig M. 2015. Development and characterization of polyclonal peptide antibodies for the detection of yellow fever virus proteins. J Virol Methods 222:110-116. http://dx.doi.org/10.1016/j.jviromet.2015.06.006.
29. Inoue S, Alonzo MT, Kurosawa Y, Mapua CA, Reyes JD, Dimaano EM, Alera MT, Saito M, Oishi K, Hasebe F, Matias RR, Natividad FF, Morita K. 2010. Evaluation of a dengue IgG indirect enzyme-linked immunosorbent assay and a Japanese encephalitis IgG indirect enzyme-linked immunosorbent assay for diagnosis of secondary dengue virus infection. Vector Borne Zoonotic Dis 10:143-150. http://dx.doi.org/10.1089/vbz.2008.0153.
30. Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH. 1985. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726-733. http://dx.doi.org/10.1126/science.4023707.
31. Yu F, Khairullah NS, Inoue S, Balasubramaniam V, Berendam SJ, Teh LK, Ibrahim NS, Abdul Rahman S, Hassan SS, Hasebe F, Sinniah M, Morita K. 2006. Serodiagnosis using recombinant nipah virus nucleocapsid protein expressed in Escherichia coli. J Clin Microbiol 44:3134-3138. http://dx.doi.org/10.1128/JCM.00693-06.
32. Kinoshita H, Mathenge EG, Hung NT, Huong VT, Kumatori A, Yu F, Parquet MC, Inoue S, Matias RR, Natividad FF, Morita K, Hasebe F. 2009. Isolation and characterization of two phenotypically distinct dengue type-2 virus isolates from the same dengue hemorrhagic fever patient. Jpn J Infect Dis 62:343-350.
33. Espada-Murao LA, Morita K. 2011. Delayed cytosolic exposure of Japanese encephalitis virus double-stranded RNA impedes interferon activation and enhances viral dissemination in porcine cells. J Virol 85:6736-6749. http://dx.doi.org/10.1128/JVI.00233-11.
34. Okamoto K, Kinoshita H, del Carmen Parquet M, Raekiansyah M, Kimura D, Yui K, Islam MA, Hasebe F, Morita K. 2012. Dengue virus strain DEN2 16681 utilizes a specific glycochain of syndecan-2 proteoglycan as a receptor. J Gen Virol 93:761-770. http://dx.doi.org/10.1099/vir.0.037853-0.
35. Ngwe Tun MM, Thant KZ, Inoue S, Kurosawa Y, Lwin YY, Lin S, Aye KT, Thet Khin P, Myint T, Htwe K, Mapua CA, Natividad FF, Hirayama K, Morita K. 2013. Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar. J Med Virol 85:1258-1266. http://dx.doi.org/10.1002/jmv. 23577.
36. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375:291-298. http://dx.doi.org/10.1038/375291a0.
37. Modis Y, Ogata S, Clements D, Harrison SC. 2005. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79:1223-1231. http://dx.doi.org/10.1128/JVI.79.2.1223-1231.2005.
38. Modis Y, Ogata S, Clements D, Harrison SC. 2003. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100:6986-6991. http://dx.doi.org/10.1073/pnas.0832193100.
39. Sánchez MD, Pierson TC, McAllister D, Hanna SL, Puffer BA, Valentine LE, Murtadha MM, Hoxie JA, Doms RW. 2005. Characterization of neutralizing antibodies to West Nile virus. Virology 336:70-82. http://dx.doi.org/10.1016/j.virol.2005.02.020.
40. Lelli D, Moreno A, Brocchi E, Sozzi E, Capucci L, Canelli E, Barbieri I, Zeller H, Cordioli P. 2012. West Nile virus: characterization and diagnostic applications of monoclonal antibodies. Virol J 9:81. http://dx.doi.org/10.1186/1743-422X-9-81.
41. Mei L, Wu P, Ye J, Gao G, Shao L, Huang S, Li Y, Yang X, Chen H, Cao S. 2012. Development and application of an antigen capture ELISA assay for diagnosis of Japanese encephalitis virus in swine, human and mosquito. Virol J 9:4. http://dx.doi.org/10.1186/1743-422X-9-4.
42. Zanluca C, Mazzarotto GA, Bordignon J, Duarte Dos Santos CN. 2014. Development, characterization and application of monoclonal antibodies against Brazilian Dengue virus isolates. PLoS One 9:e110620. http://dx.doi.org/10.1371/journal.pone.0110620.
43. Houghton-Trivino N, Montana D, Castellanos J. 2008. Dengue-yellow fever sera cross-reactivity; challenges for diagnosis. Rev Salud Publica (Bogota) 10:299-307. http://dx.doi.org/10.1590/S0124-00642008000200010.
44. Koraka P, Zeller H, Niedrig M, Osterhaus AD, Groen J. 2002. Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect 4:1209-1215. http://dx.doi.org/10.1016/S1286-4579 (02) 01647-7.
45. Pierson TC, Diamond MS. 2008. Molecular mechanisms of antibodymediated neutralisation of flavivirus infection. Expert Rev Mol Med 10:e12. http://dx.doi.org/10.1017/S1462399408000665.
46. Pierson TC, Fremont DH, Kuhn RJ, Diamond MS. 2008. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 4:229-238. http://dx.doi.org/10.1016/j.chom.2008.08.004.
47. Thullier P, Demangel C, Bedouelle H, Megret F, Jouan A, Deubel V, Mazie JC, Lafaye P. 2001. Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism. J Gen Virol 82:1885-1892. http://dx.doi.org/10.1099/0022-1317-82-8-1885.
48. WHO. 2008. Annex 3. Laboratory confirmation of yellow fever diagnosis, p 66-67. In Investigation of yellow fever epidemics in Africa-field guide. WHO, Geneva, Switzerland.